This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Jennifer Codding-Bui, PhD
Senior Scientist, Protein Engineering at ATUM


Jennifer Codding-Bui’s technical expertise lies in characterizing and engineering antibodies, enzymes, and biologics. Jennifer received her Ph.D. in oxidative protein folding from the Department of Chemistry and Biochemistry at the University of Delaware. As an NRSA fellow at Columbia and Stanford Universities, Jennifer elucidated and inhibited enzymatic pathways in neurodegenerative disease. In her role as an application scientist at ForteBio, Jennifer supported over 200 academic, biotech, and pharmaceutical clients in assay development and in analyzing affinity kinetic interactions. Currently, Jennifer works on a protein engineering team at Atum, where she engineers and characterizes antibody therapeutics toward inhibiting and treating disease. Jennifer is excited to share her work combining analytical instrumentation, assay development, and AI to engineer antibody therapeutics.

Agenda Sessions

  • Multiparametric Therapeutic Antibody Optimization using High Quality Assays and Machine Learning